06929.HK
OrbusNeich Medical Group Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 3.80
+0.53%Year over year
Reported trailing growth
- Revenue
- +15.8%
- EBITDA
- +32.2%
- EBIT
- +33.3%
- EPS
- +8.5%
- Free cash flow
- +59.6%
- Operating cash flow
- -33.1%
Forward estimates
Based on analyst estimates
- Revenue
- -44.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +9.7%
- EBITDA
- +18.9%
- EBIT
- +23.5%
- Net income
- +31.3%
- EPS
- +17.1%
- Free cash flow
- -61.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026